Cytotoxic activity of isoliquiritigenin towards CCRF-CEM leukemia cells and its effect on DNA damage

Planta Medica

Volumn 75, Issue 10, 2009, Pages 1134-1140

  Zu, Yuangang ^a   Liu, Xia ^a   Fu, Yujie ^a   Shi, Xiaoguang ^a   Wu, Nan ^a   Yao, Liping ^a   Efferth, Thomas ^b  

^a NORTHEAST FORESTRY UNIVERSITY   (China)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Anticancer activity; CCRF CEM cell line; DNA damage; Isoquiritigenin (ISL)

Indexed keywords

CUPRIC ION; ISOLIQUIRITIGENIN; PLASMID DNA; ANTINEOPLASTIC AGENT; CHALCONE DERIVATIVE;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MEMBRANE DAMAGE; MITOCHONDRIAL MEMBRANE POTENTIAL; CELL DIVISION; CELL MEMBRANE POTENTIAL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL LINE, TUMOR; CELL PROLIFERATION; CHALCONES; DNA DAMAGE; G2 PHASE; HUMANS; MEMBRANE POTENTIALS; MICROSCOPY, ATOMIC FORCE;

EID: 70350776722     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1185479     Document Type: Article

References (35)

1. Yamazaki S, Morita T, Endo H, Hamamoto T, Baba M, Joichi Y, Kaneko S, Okada Y, Okuyama T, Nishino H, Tokue A. Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma. Cancer Lett 2002; 183: 23-30
2. Kumar S, Sharma A, Madan B, Singhal V, Ghosh B. Isoliquiritigenin inhibits IkB kinase activity and ROS generation to block TNF-a induced expression of cell adhesion molecules on human endothelial cells. Biochem Pharmacol 2007; 73: 1602-1612
3. Hsu YL, Kuo PL, Lin CC. Isoliquiritigenin induces apoptosis and cell cycle arrest through p53-dependent pathway in Hep G2 cells. Life Sci 2005; 77: 279-292
4. Haraguchi H, Ishikawa H, Mizutani K, Tamura Y, Kinoshita T. Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflate. Bioorg Med Chem 1998; 6: 339-347
5. Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wähälä K, Montesano R, Schweigerer L. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 1997; 57:2916-2921
6. Carlson B, Lahusen T, Singh S, Loaiza-Perez A,Worland PJ, Pestell R, Albanese C, Sausville EA, Senderowicz AM. Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol. Cancer Res 1999; 59: 4634-4641
7. TawataM, Aida K, Noguchi T, Ozaki Y, Kume S, Sasaki H, ChinM, Onaya T. Anti-platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice. Eur J Pharmacol 1992; 212: 87-92
8. Wegener JW, Nawrath H. Cardiac effects of isoliquiritigenin. Eur J Pharmacol 1997; 326: 37-44
9. Jung JI, Lim SS, Choi HJ, Cho HJ, Shin HK, Kim EJ, ChungWY, Park KK, Park JH. Isoliquiritigenin induces apoptosis by depolarizing mitochondrial membranes in prostate cancer cells. J Nutr Biochem 2006; 17: 689-696
10. Kanazawa M, Satomi Y, Mizutani Y, Ukimura O, Kawauchi A, Sakai T, Baba M, Okuyama T, Nishino H, Miki T. Isoliquiritigenin inhibits the growth of prostate cancer. Eur Urol 2003; 43: 580-586
11. Yamazaki S, Morita T, Endo H, Hamamoto T, Baba M, Joichi Y, Kaneko S, Okada Y, Okuyama T, Nishino H, Tokue A. Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma. Cancer Lett 2002; 183: 23-30
12. Ii T, Satomi Y, Katoh D, Shimada J, Baba M, Okuyama T, Nishino H, Kitamura N. Induction of cell cycle arrest and p21CIP1/WAF1 expression in human lung cancer cells by isoliquiritigenin. Cancer Lett 2004; 207: 27-35
13. Chen CJ, Hsu MH, Huang LJ, Yamori T, Chung JG, Lee FY, Teng CM, Kuo SC. Anticancer mechanisms of YC-1 in human lung cancer cellline, NCIH226. Biochem Pharmacol 2008; 75: 360-368
14. Ma J, Fu NY, Pang DB, Wu WY, Xu AL. Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells. Planta Med 2001; 67: 754-757
15. Efferth T, Davey M, Olbrich A, Rücker G, Gebhart E, Davey R. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1-or MRP1-overexpressingmultidrug-resistant human CCRF-CEM leukemia cells. Blood Cell Mol Dis 2002; 28: 160-168
16. Chowdhury SA, Kishino K, Satoh R, Hashimoto K, Kikuchi H, Nishikawa H, Shirataki Y, Sakagami H. Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids. Anticancer Res 2005; 25: 2055-2063
17. Pogozelski WK, Tullius TD. Oxidative strand scission of nucleic acids: routes initiated by hydrogen abstraction from the sugar moiety. Chem Rev 1998; 98: 1089-1107
18. Cardozo-Pelaez F, Brooks PJ, Stedeford T, Song S, Sanchez-Ramos J. DNA damage, repair, and antioxidant systems in brain regions: a correlative study. Free Radic Biol Med 2000; 28: 779-785
19. Zhang Q, Pan J, Zhao C,Wang Y, Jia Z, Zheng R. Non-enzymatic fast repair of DNA oxidative damage might also exist in cells. Cell Biol Int 2008; 32: 654-662
20. Wang T, Chen LX, Long Y, WuWM,Wang R. DNA damage induced by caffeic acid phenyl ester in the presence of Cu(II) ions: Potential mechanism of its anticancer properties. Cancer Lett 2008; 263: 77-88
21. Sakano K, Kawanishi S. Metal-mediated DNA damage induced by curcumin in the presence of human cytochrome P450 isozymes. Arch Biochem Biophys 2002; 405: 223-230
22. Cao J, Liu Y, Jia L, Zhou HM, Kong Y, Yang G, Jiang LP, Li QJ, Zhong LF. Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells. Free Radic Biol Med 2007; 43: 968-975
23. Sun YL, Zhong WJ. Curcumin-induced oxidative damage of plasmid DNA. Environ Occup Med 2006; 23: 31-33
24. Hansma HG, Kasuya K, Oroudjev E. Atomic force microscopy imaging and pulling of nucleic acids. Curr Opin Struct Biol 2004; 14: 380-385
25. Shlyakhtenko LS, Gall AA, Filonov A, Cerovac Z, Lushnikov A, Lyubchenko YL. Silatrane-based surface chemistry for immobilization of DNA, protein-DNA complexes and other biological materials. Ultramicroscopy 2003; 97: 279-287
26. Cai YJ, Wei QY, Fang JG, Yang L, Liu ZL, Wyche JH, Han Z. The 3,4-dihydroxyl groups are important for trans-resveratrol, analogs to exhibit enhanced antioxidant and apoptotic activities. Anticancer Res 2004; 24: 999-1002
27. Sabzevari O, Galati G, Moridani MY, Siraki A, O'Brien PJ. Molecular cytotoxic mechanisms of anticancer hydroxychalcones. Chem Biol Interact 2004; 148: 57-67
28. Azmi AS, Bhat SH, Hanif S, Hadi SM. Plant polyphenols mobilize endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for anticancer properties. FEBS Lett 2006; 580: 533-538 (Pubitemid 43089682)
29. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004; 432: 316-323
30. Speit G, Hochsattel R, Vogel W. The contribution of DNA single-strand breaks to the formation of chromosome aberrations and SCEs. Basic Life Sci 1984; 29: 229-244
31. Zheng LF, Dai F, Zhou B, Yang L, Liu ZL. Prooxidant activity of hydroxycinnamic acids on DNA damage in the presence of Cu(II) ions: mechanism and structure-activity relationship. Food Chem Toxicol 2008; 46: 149-156
32. Taskov H, Dimitrova E, Serbinova M, Mendisova L, Bobev D. Immunological subtypes of childhood acute lymphoblastic leukemia in Bulgaria. Leuk Res 1995; 19: 877-881
33. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9: 1783-1786
34. Dartsch DC, Schaefer A, Boldt S, Kolch W, Marquardt H. Comparison of anthracycline-induced death of human leukemia cells: programmed cell death versus necrosis. Apoptosis 2002; 7: 537-548
35. Min DJ, Moskowitz NP, Brownstein C, Lee H, Horton TM, Carroll WL. Diverse pathways mediate chemotherapy-induced cell death in acute lymphoblastic leukemia cell lines. Apoptosis 2006; 11: 1977-1986